A powerhouse of genomic information has led to a revamped tumor classification system that reclassifies as many as one out of every 10 cancer cases, according to a meta-analysis published Aug. 7 in the journal Cell.

Neuraceq (F-18 florbetaben) became available for commercial use on Aug. 1 and went into action for clinical PET imaging of beta-amyloid in the brain at WVU Healthcare in West Virginia, Piramal Imaging announced today.

Superb micro-vascular imaging helps clinicians deliver a more accurate diagnosis. Toshiba is making it possible for clinicians to use ultrasound to see the smallest vessels in and around areas like tumors and lymph nodes, giving them a new way to diagnose disease faster and non-invasively.

Low levels of vitamin D are associated with all-cause dementia, including Alzheimer’s disease (AD), according to the largest multicenter population study published Aug. 6 in Neurology. 

More than $300,000 will go toward genomic research by African investigators carried out in Africa, according to an announcement Aug. 3 from the National Institutes of Health (NIH).

A round up of genomics research is presented in this Telegraph anthology of recent articles from international news sources. Millions of dollars are being funneled into a project to "unlock"  DNA, personal genomics could become second nature, and challenges that have held up the science of genomics and its applications are presented.

A high uptake of FDG could signal glucose hypermetabolism in muscle, making FDG PET a novel addition to more conventional methods of detecting denervation, according to a study published Aug. 7 in the Journal of Nuclear Medicine.

Varian Medical Systems announced Aug. 5 that the company acquired dose calculation software produced by Transpire to merge with treatment planning technology.